SYNJ1 was first reported in relation to autosomal recessive Developmental Epileptic Encephalopathy (DEE) in 2015 (Dyment et al. 2015 PMID: 25316601). Besides DEE, SYNJ1 has been associated with autosomal recessive Parkinson disease, early onset. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found difference in phenotypes of these diseases. Therefore, the following disease entities have been split into two disease entities, Developmental and epileptic encephalopathy (OMIM:617389) and Parkinson disease, early onset (OMIM:615530). The split curation for autosomal recessive Parkinson disease, early onset may be curated by Parkinson disease GCEP. Eight SYNJ1 variants that have been reported in seven probands in five publications have been included in this curation. Typical phenotypes of these probands were neonatal onset seizures, hypotonia, severe to profound global developmental delay, and quadriplegia. Of the seven reported families, five had biallelic loss-of-function variants, and the default point of 1.5 was awarded for each allele, resulting in 15 points. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be LOF. This gene-disease association is also supported by an animal model (PMID: 10535736). The SYNJ1 knockout mice with seizures, failure to thrive, and ataxia, which manifest immediately after birth was given 2 points. In summary, SYNJ1 is definitively associated with autosomal recessive DEE. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.